Results 131 to 140 of about 372,643 (301)

Introduction and enlightenment of the Recommendations and Expert Consensus for Plasm a and Platelet Transfusion Practice in Critically ill Children: from the Transfusion and Anemia Expertise Initiative-Control/Avoidance of Bleeding (TAXI-CAB)

Zhongguo shuxue zazhi
To guide transfusion practice in critically ill children who often need plasma and platelet transfusions, the Transfusion and Anemia Expertise Initiative-Control/Avoidance of Bleeding (TAXI-CAB) developed Recommendations and Expert Consensus for Plasma ...
LU Lu, ZENG Jiaohui, TANG Hao, GU Lan, ZHANG Junhua, LIN Zhi, WANG Dan, ZHAO Mingyi, YANG Minghua, HUANG Rong, GUI Rong   +10 more
doaj   +1 more source

You may need a blood transfusion

, 2021
This leaflet is designed to help you and your family understand what a blood transfusion is and how you can help make this a safer treatment for you. Your doctor or nurse will explain if you are likely to need a blood transfusion and why. They will
National Transfusion Advisory Group (NATG)
core  

Association Between Blood Transfusion for Postpartum Haemorrhage and the Risk of Premature Ovarian Failure: A Nationwide Population‐Based Cohort Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To investigate the association between postpartum haemorrhage (PPH) severity and the subsequent risk of premature ovarian failure (POF), with blood transfusion used as a marker of severe PPH: Design Nationwide population‐based retrospective cohort study. Setting Korean National Health Insurance Service (KNHIS) database.
Min‐A Kim, Ju Hyeong Son, Hyun‐Joo Seol, Min‐Jeong Oh, Geum Joon Cho, Young‐Han Kim   +5 more
wiley   +1 more source

Platelet Transfusion

Current Opinion in Hematology
Purpose of review Platelet transfusions, used as prophylaxis or treatment for bleeding, are potentially life-saving. In many countries, demand for platelet transfusion is rising. Platelets are a limited and costly resource, and it is vital that they are used appropriately.
Agarwal A, Khan AI, Anwer F.
europepmc   +3 more sources

Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system

, 2018
Background. Despite improvements in blood donor selection and screening procedures, transfusion recipients can still develop complications related to infections by known and emerging pathogens. Pathogen reduction technologies (PRT) have been developed to
Spagnolo A. G., Urbina L. I., Pupella S., Veropalumbo E., Fiore A., Midolo E., Farina B., Refolo P., Coretti S., Sacco F., Pati I., Marano G., Sacchini D., Cicchetti A., Liumbruno G. M., Rebulla P., Rumi F., Bidino R. D.   +17 more
core   +1 more source

Immune response to platelet transfusions

Current Opinion in Hematology
Purpose of review Platelet transfusion can have a significant immunological impact, exposing the recipient to alloantigens on the surface of platelets and contaminating leukocytes, a dynamic range of soluble immune mediators, and donor platelets that can directly and indirectly contribute to the inflammatory profile of the ...
Jackman, Rachael P., Thomas, Kimberly A.
openaire   +2 more sources

Efficiency comparison between new single‐needle dialysis and conventional double‐needle dialysis and exploration of the optimal prescription parameters for single‐needle hemodialysis

Therapeutic Apheresis and Dialysis, Volume 29, Issue 3, Page 419-427, June 2025.
Abstract Objective To compare the dialysis efficiency parameters between new single‐needle dialysis and conventional double‐needle dialysis and to explore the optimal prescription parameters for single‐needle hemodialysis. Methods This study involved a prospective, cross‐over design. Eight patients were randomly divided into two cohorts, which received
Bin Zhao, Shen Zhan, Gang Fu, Shanshan Guo, Lifang Liu, Wei Liu, Guanghui Xiao, Yuzhu Wang, Lihong Zhang   +8 more
wiley   +1 more source

Interventional oncology in children: Where are we now?

Journal of Medical Imaging and Radiation Oncology, EarlyView.
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel, Fernando Gómez Muñoz   +1 more
wiley   +1 more source

Platelet Transfusion:2025 AABB and ICTMG International Clinical Practice Guidelines

Importance: Platelet transfusion is a frequent procedure with benefits and risks. Objective: To provide recommendations in adult and pediatric populations in whom platelet transfusions are commonly performed.
Kranke, Peter, Fung, Mark K., Metcalf, Ryan A., Bathla, Aarti, Murphy, Michael F., Møller, Morten H., DeAnda, Abe, Saifee, Nabiha H., Waters, Jonathan, Hess, Aaron S., Jug, Rachel C., Kaufman, Richard M., Hume, Heather A., Uberoi, Raman, Szczepiorkowski, Zbigniew M., Callum, Jeannie L., Al-Riyami, Arwa Z., Pagano, Monica B., Patidar, Gopal K., Louw, Vernon J., Zeller, Michelle P., Guyatt, Gordon, Muszynski, Jennifer A., Stolla, Moritz, Pavenski, Katerina, Desimone, Robert A., Nahirniak, Susan, Estcourt, Lise J., O'kelly, Cian J., Poston, Jacqueline N., Cohn, Claudia S., Goel, Ruchika, La Rocca, Ursula, Williams, Brittney, White, Sandra K., Wood, Erica M., Stanworth, Simon J., Zantek, Nicole D., Filipescu, Daniela C., Grossman, Brenda J., Tobian, Aaron A. R., Dubon, Allan   +41 more
core   +1 more source

Myeloablative Busulfan, Fludarabine and Melphalan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Childhood Myeloid Malignancy

Asia-Pacific Journal of Clinical Oncology, EarlyView.
We report our single‐center experience of transplant outcomes with a busulfan, fludarabine and melphalan‐based conditioning regimen for children < 18 years of age. The regimen was shown to be well tolerated and effective for heavily pretreated children with high‐risk myeloid malignancies prior to allogeneic hematopoietic stem cell transplant.
Mayank Dhamija, Fiona Kerr, Hazel Gough, Johnathan Soggee, Laurence C. Cheung, Rishi S. Kotecha, Shanti Ramachandran   +6 more
wiley   +1 more source